David Browning

Director Clinical Operations Oncology USA

David Browning

David Browning has over 24 years of clinical drug development experience working in the pharmaceutical industry, contract research organization (CRO) and academic settings. While at the NCI-designated Comprehensive Cancer Center, Vanderbilt-Ingram Cancer Center, he oversaw the daily operations of the Clinical Trials Office, which was responsible for over 175 oncology trials and 13 INDs, and has directly managed over 30 phase I through III clinical trials worldwide from research through drug approval.